Xiang lab - Cancer Immunol Immunother paper

CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8+CD103+ cDC1 and TRM cell responses

Wu Z, Yang Z, Iftikhar T, Groot G, Leary SC, Baniak N, Ahmed S, Bosch M, Moser M, Zhang W, Jiang J, Xiang J. Cancer Immunol Immunother. 2025 Nov 18;74(12):378. doi: 10.1007/s00262-025-04217-7. PMID: 41251836